SUSAN ZIMMERMAN: Open Payments
NPI 1467558528 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 46 payments from 14 companies in 2025. Trend: 2023 $446 · 2024 $589 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 11 | $279 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $211 |
| AstraZeneca Pharmaceuticals LP | 4 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $177 |
| E.R. Squibb & Sons, L.L.C. | 6 | $173 |
| Abbott Laboratories | 1 | $129 |
| Amgen Inc. | 2 | $57 |
| PFIZER INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ABIOMED | 1 | $24 |
Products named: Optimizer, JARDIANCE, Kerendia, CARDIOMEMS, LOKELMA, FARXIGA, VYNDAQEL, CAMZYOS.
Industry payments across NJ — which companies pay providers there.
